SAMOTHRACE: Telemonitoring in Patients With Advanced Chronic Liver Disease
SAMOTHRACE is a prospective, single-center, randomized controlled pilot study evaluating a home-based telemonitoring strategy in patients with advanced chronic liver disease undergoing follow-up for advanced therapies and/or liver transplantation. Participants were randomized in a 1:2 ratio to a telemonitoring intervention or standard care. The telemonitoring strategy combines home acquisition and transmission of physiological parameters with centralized clinical review and predefined alerts. Participants were followed for 12 months. The primary objective was to assess the feasibility of remote patient management, while secondary objectives included liver-related clinical outcomes, hospital readmissions, liver transplantation, and mortality.
Gender: All
Ages: 18 Years - Any
Liver Disease Chronic
Advanced Therapy
Liver Transplantation (LT)